Florian Scherer
Florian Scherer
Clinician Scientist and PI, Hematology and Oncology, University Medical Center Freiburg
Adresse e-mail validée de uniklinik-freiburg.de
Titre
Citée par
Citée par
Année
Integrated digital error suppression for improved detection of circulating tumor DNA
AM Newman*, AF Lovejoy*, DM Klass* (Co-First), DM Kurtz, JJ Chabon, ...
Nature biotechnology 34 (5), 547-555, 2016
6802016
Determining cell type abundance and expression from bulk tissues with digital cytometry
AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ...
Nature biotechnology 37 (7), 773-782, 2019
5862019
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
JJ Chabon*, AD Simmons* (Co-First), AF Lovejoy, MS Esfahani, ...
Nature communications 7 (1), 1-15, 2016
4652016
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
Cancer discovery 7 (12), 1394-1403, 2017
3522017
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
F Scherer*, DM Kurtz*, AM Newman* (Co-First), H Stehr, AFM Craig, ...
Science translational medicine 8 (364), 364ra155-364ra155, 2016
2492016
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz*, MR Green* (Co-First), SV Bratman, F Scherer, CL Liu, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
2252015
Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma
DM Kurtz*, F Scherer* (Co-First), MC Jin, J Soo, AFM Craig, MS Esfahani, ...
Journal of Clinical Oncology 36 (28), 2845, 2018
1702018
Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction
DM Kurtz*, MS Esfahani*, F Scherer* (Co-First), J Soo, MC Jin, CL Liu, ...
Cell 178 (3), 699-713. e19, 2019
812019
High-throughput sequencing for noninvasive disease detection in hematologic malignancies
F Scherer*, DM Kurtz* (Co-First), M Diehn, AA Alizadeh
Blood 130 (4), 440-452, 2017
552017
Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia
J Duque-Afonso, J Feng, F Scherer, CH Lin, SHK Wong, Z Wang, ...
The Journal of clinical investigation 125 (9), 3667-3680, 2015
472015
Organocatalytic removal of formaldehyde adducts from RNA and DNA bases
S Karmakar, EM Harcourt, DS Hewings, F Scherer, AF Lovejoy, DM Kurtz, ...
Nature chemistry 7 (9), 752-758, 2015
442015
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7: 1394–1403. doi: 10.1158/2159-8290
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
CD-17-0716.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
33
Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation
F Scherer, MA Navarrete, C Bertinetti-Lapatki, J Boehm, A Schmitt-Graeff, ...
Leukemia & lymphoma 57 (1), 151-160, 2016
172016
Noninvasive genotyping and assessment of treatment response in diffuse large B cell lymphoma
F Scherer, DM Kurtz, AM Newman, H Stehr, CL Liu, L Zhou, AFM Craig, ...
Blood, The Journal of the American Society of Hematology 126 (23), 114-114, 2015
142015
Age-related gliosis promotes central nervous system lymphoma through CCL19-mediated tumor cell retention
T O'Connor, X Zhou, J Kosla, A Adili, MG Beccaria, E Kotsiliti, D Pfister, ...
Cancer cell 36 (3), 250-267. e9, 2019
132019
Development and validation of biopsy-free genotyping for molecular subtyping of diffuse large B-cell lymphoma
F Scherer, DM Kurtz, AM Newman, MS Esfahani, A Craig, H Stehr, ...
Blood 128 (22), 1089, 2016
132016
Dynamic noninvasive genomic monitoring for outcome prediction in diffuse large B-cell lymphoma
DM Kurtz, F Scherer, AM Newman, AF Lovejoy, DM Klass, JJ Chabon, ...
Blood, The Journal of the American Society of Hematology 126 (23), 130-130, 2015
132015
Development and clinical validation of discriminatory multitarget digital droplet PCR assays for the detection of hot spot KRAS and NRAS mutations in cell-free DNA
S Hussung, M Follo, RFU Klar, S Michalczyk, K Fritsch, F Nollmann, ...
The Journal of Molecular Diagnostics 22 (7), 943-956, 2020
112020
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study
E Schorb, B Kasenda, G Ihorst, F Scherer, J Wendler, L Isbell, H Fricker, ...
Blood advances 4 (14), 3378, 2020
92020
Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics.
DM Kurtz, F Scherer, AM Newman, AFM Craig, MS Khodadoust, ...
Journal of Clinical Oncology 34 (15_suppl), 7511-7511, 2016
92016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20